20-Year Steady Increase in Survival of Patients with Acute Lymphoblastic Leukemia
Ali Bazarbachi, Professor of Medicine (Hematology and Oncology) and Director of the bone marrow transplantation program at the American University of Beirut-Medical Center, presents in this MEDtalk a 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in